US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis

RSS Feeds

Manufacturing, Packaging & Detailing Industry Research & Market Reports

3  4  5  6    8    10  11  12  
Pharmacy Automation Systems Market by product type (Medication Dispensing Systems, Packaging and Labeling Systems, Table-top Counters) & by End-user (Inpatient Pharmacy Automation, Outpatient Pharmacy Automation) - Global Forecasts & Trends to 2019
8/6/2014 | published by: MarketsandMarkets
... automation systems market research report studies and analyzes the pharmacy automation systems market by product and end user. The market by product includes pharmacy automation systems such as automated medication dispensing systems, automated packaging and ...  |  read more...
USD 4,650
Malaysia Healthcare Outlook
8/12/2014 | published by: Frost & Sullivan
... investors, and the distributor network has also been included. This study does broadly discuss the revenue or financial forecasting of the healthcare industry, but does not address the companies which are involved with R&D or ...  |  read more...
USD 6,000
Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market
7/31/2014 | published by: GBI Research
... research report, “Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market”. The value of the Non-Small Cell Lung Cancer (NSCLC) market is ...  |  read more...
USD 4,995
Pharmaceuticals and Healthcare Report - Angola Q4 2014
8/27/2014 | published by: Business Monitor International
... attracting external revenues. Angola'shigh burden of communicable disease, such as measles and malaria, will mean that the demand forvaccines remain high. However, the country's pharmaceutical and healthcare market is greatly affected byits difficult operating environment, ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Argentina Q4 2014
8/27/2014 | published by: Business Monitor International
... erode the growth ofthe country's pharmaceutical market. More foreign pharmaceutical companies will cease their localoperations, if the hostile business environment is worsened. Headline Expenditure Projections Pharmaceuticals: ARS39.30bn (USD7.18 bn) in 2013 to ARS50.10bn (USD6.04bn) in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Colombia Q4 2014
8/27/2014 | published by: Business Monitor International
... bioequivalence regulationswill also undermine sale growth posted by branded generic drugmakers. However, Colombia's relativelyadvanced drug reimbursement system will still offer revenue-generating opportunities for multinationals incomparison with other second-tier Latin American pharmaceutical markets. Headline Expenditure Projections ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Mozambique Q4 2014
8/27/2014 | published by: Business Monitor International
... medicines and healthcare facilities. Vaccination programs and trials are being put into place, particularly for malaria and HIV immunisation,to help combat the county's high burden of disease. However, Mozambique's pharmaceutical market suffersfrom an abundance of ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Netherlands Q4 2014
8/27/2014 | published by: Business Monitor International
... austerity measures to meet the terms of EUbudget criteria and further restrictions on drug expenditure look likely, particularly on essential medicines. Although healthcare expenditure continues to increase (in local currency terms), we maintain our view ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Uganda Q4 2014
8/27/2014 | published by: Business Monitor International
... healthcare coverage which results in mostUgandans being unable to afford medicines, is placing a high level of strain on the country's ability toprovide adequate healthcare. Uganda also faces the threat of an Ebola outbreak spreading ...  |  read more...
USD 1,295
Analyzing the Global Market for Active Pharmaceutical Ingredients
9/1/2014 | published by: Aruvian's R'search
... as investments made by the major players went down significantly. Furthermore with a large number of blockbuster drugs going off patent by the end of 2014, there is expected to be a major impact on ...  |  read more...
USD 1,750
Scientific Research and Development (R&D) Industry, in Telecommunications, Computers, Physical Sciences, Medical Devices and Pharmaceuticals Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541700
8/26/2014 | published by: Plunkett Research, Ltd.
... benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Scientific Research and Development (R&D) Industry, in Telecommunications, Computers, Physical Sciences, Medical Devices and Pharmaceuticals Industry (U.S.) to reach ...  |  read more...
USD 1,995
Cameroon Pharmaceuticals and Healthcare - Report Q4 2014
9/3/2014 | published by: Business Monitor International
... sectorimprovement in Cameroon over the medium term. These include mobile health technologies implementationin the fields of cardiology, HIV testing and personalised medical information across the country, as well ashospitals construction, foreign aid projects and different ...  |  read more...
USD 1,295
Analyzing the Global Generics Industry 2014
8/1/2014 | published by: Aruvian's R'search
... patent expiries has put a focus on the global generics industry. Over the years, the global generic drugs industry has grown strongly owing partly to the fact that the period for patent protection has gotten ...  |  read more...
USD 1,750
Acne Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... by value •Deals listed by company A-Z, industry sector, stage of development, technology type Acne Partnering 2009-2014 provides understanding and access to the acne partnering deals and agreements entered into by the worlds leading healthcare ...  |  read more...
USD 695
Genitourinary Partnering Terms and Agreements
8/1/2014 | published by: Current Partnering
... report provides a detailed understanding and analysis of how and why companies enter genitourinary partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right ...  |  read more...
USD 1,995
Nigeria Pharmaceuticals and Healthcare - Report Q4 2014
9/3/2014 | published by: Business Monitor International
... downside risk to increasinggovernment revenue, healthcare provision and medicines uptake over the long term. Currently, thegovernment remains committed to improving healthcare infrastructure and quality across the country. Wesee Nigeria as a standout market in West ...  |  read more...
USD 1,295
Turkey Pharmaceuticals and Healthcare - Report Q4 2014
9/3/2014 | published by: Business Monitor International
... higher yo-y growth rates return from 2013/14. In contrast to European markets where manufacturers can expect toachieve higher prices, but with a stagnant growth outlook, Turkey offers strong growth potential ifdrugmakers are able to accept ...  |  read more...
USD 1,295
Romania Pharmaceutical Report - Q2, 2014
9/4/2014 | published by: Intellinews
... to RON 3bn (EUR 679.8mn) in Q2/2014, returning to growth after having declined on an annual basis for three consecutive quarters. In volume terms, the market also rose by 3.2% y/y in Q2, recovering from ...  |  read more...
USD 475
Binge Eating Disorder - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... information on the therapeutic development for Binge Eating Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Anti-Counterfeiting Packaging Market by Technology (Authentication & Anti-Tempering, and Track & Trace), by Application (Food & Beverage, Pharmaceuticals, and Others) - Global Trends & Forecast to 2019
8/12/2014 | published by: MarketsandMarkets
... is projected to record a CAGR of 14.1% from 2014 to 2019. The estimation is a result of new products & technologies launches in the industry, with increase in application of anti-counterfeit in different economies. ...  |  read more...
USD 4,650
Best Practices - 2014 Life Science Manufacturing and Supply Chain IT Benchmark Guide
8/12/2014 | published by: IDC
... projected to experience strengthening growth going forward. Eric Newmark, program director at IDC Health Insights, commented, "Life science companies are exploring opportunities to further optimize manufacturing and supply chain processes to help solve several industry ...  |  read more...
USD 4,500
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia
9/1/2014 | published by: GlobalData
... information on and analysis of the healthcare, regulatory and reimbursement landscape in Australia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare ...  |  read more...
USD 1,995
Kenya Pharmaceuticals and Healthcare Report - Q4 2014
8/20/2014 | published by: Business Monitor International
... healthcare spending between2013 and 2018. However, we note that there are downside risks to our forecast, including governmentinefficiencies and the out-of-pocket characteristics of the market, which will act as challenges forcompanies looking for a rapid ...  |  read more...
USD 1,295
Thailand Pharmaceuticals and Healthcare Report - Q4 2014
8/20/2014 | published by: Business Monitor International
... with access tohealthcare. However cost containment policies and delays in patent approvals limit the attractiveness of thecountry to multinational pharmaceutical firms. Headline Expenditure Projections Pharmaceuticals: THB142.5bn (USD4.64bn) in 2013 to THB146.5bn (USD4.5bn) in 2014; +2.8% ...  |  read more...
USD 1,295
Brazil Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... aresignificant revenue-generating opportunities for drugmakers, medical device companies and healthcareservice providers. However, multinationals will continue to face increasing government intervention anddomestic competition. Headline Expenditure Projections Pharmaceuticals: BRL57.0bn (USD26.4bn) in 2013 to BRL62.0bn (USD26.6bn) in 2014; ...  |  read more...
USD 1,295
3  4  5  6    8    10  11  12